BioSpace News Archive

Dr. Alberico Sessa Decreases Facelift Scarring And Recovery Time With Revolutionary SmartLift™.

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders and pain, announced the appointment of Christopher J. Coughlin to its board of directors.

The objective of the trial is to evaluate the efficacy and safety of plitidepsin in patients with COVID-19 requiring hospital admission

The designation is for L‑CsA‑i for the treatment of bronchiolitis obliterans syndrome, developed by Breath Therapeutics, a Zambon company.

TherapeuticsMD, Inc., an innovative women’s healthcare company, announced that it will report its first quarter 2020 financial results on Wednesday, May 6, 2020, before the opening of the U.S. financial markets.

Sharps Compliance Corp. reported financial results for the third quarter and first nine months of fiscal year 2020 ended March 31, 2020.

Waters Corporation announced first quarter 2020 sales of $465 million, a 10% decrease as reported, compared to sales of $514 million for the first quarter of 2019.

Antares Pharma, Inc. announced it will release its first quarter 2020 financial results and recent operating progress before the market opens on Tuesday, May 5, 2020.

Management to Host Webcast and Conference Call Today at 8:30 A.M. ET

AMAG Pharmaceuticals, Inc. announced that its Board of Directors has appointed Scott Myers as AMAG’s President and Chief Executive Officer, and member of the Board, effective immediately.